Confluence is a bioscience company that engages in research and development of drugs for the treatment of cancer, autoimmune and inflammatory diseases... Read more
Confluence is a bioscience company that engages in research and development of drugs for the treatment of cancer, autoimmune and inflammatory diseases... Read more
News
Nov 26, 2019
BioPortfolio
Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $220
Oct 20, 2018
BioPortfolio
Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250
Aug 02, 2018
BioPortfolio
Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 16, 2018
BioPortfolio
Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Nov 15, 2017
BioPortfolio
Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250
Aug 14, 2017
BioPortfolio
Confluence Life Sciences: Confluence Life Sciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 26072017 Prices from USD $250
Aug 10, 2017
VentureBeat
Confluence Life Sciences: Confluence's $100 million acquisition a win for St. Louis' biotech sector
Aug 09, 2017
The Business Journals
Confluence Life Sciences: St. Louis' BioGenerator playbook helped facilitate $100M Confluence deal
Aug 08, 2017
BioSpace
Confluence Life Sciences: Aclaris Scoops Up St. Louis Startup in Deal Worth Up to $100M
Aug 07, 2017
The Business Journals
Confluence Life Sciences: Houston VC-funded startup acquired in deal valued at $100 million
Confluence Life Sciences Competitors
1
2
3
4
5
6
7
8
9
10